All Stories

  1. An Innovative Approach to Extending the Antidepressant Effects of Intravenous Ketamine in Major Depression

    Article • American Journal of Psychiatry, December 2022, American Psychiatric Association

    alan schatzberg

  2. Understanding the Efficacy and Mechanism of Action of a Dextromethorphan-Bupropion Combination: Where Does It Fit in the NMDA Versus mu-Opioid Story?

    Article • American Journal of Psychiatry, July 2022, American Psychiatric Association

    alan schatzberg

  3. Mechanisms of Action of Ketamine and Esketamine

    Article • American Journal of Psychiatry, December 2021, American Psychiatric Association

    alan schatzberg

  4. Some Comments on Psychedelic Research

    Article • American Journal of Psychiatry, May 2020, American Psychiatric Association

    alan schatzberg

  5. More Thoughts on Intranasal Esketamine: Response to Drevets et al.

    Article • American Journal of Psychiatry, October 2019, American Psychiatric Association

    alan schatzberg

  6. A Word to the Wise About Intranasal Esketamine

    Article • American Journal of Psychiatry, May 2019, American Psychiatric Association

    alan schatzberg

  7. Scientific Issues Relevant to Improving the Diagnosis, Risk Assessment, and Treatment of Major Depression

    Article • American Journal of Psychiatry, May 2019, American Psychiatric Association

    alan schatzberg

  8. Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism

    Article • American Journal of Psychiatry, December 2018, American Psychiatric Association

    Dr. Nolan R Williams, alan schatzberg

  9. The chicken and egg of anxiety and depression

    Article • Epidemiology and Psychiatric Sciences, May 2015, Cambridge University Press

    alan schatzberg

  10. Issues encountered in recent attempts to develop novel antidepressant agents

    Article • Annals of the New York Academy of Sciences, March 2015, Wiley

    alan schatzberg